Showing results (311-320 of 623) with videos related to
Sort By:
Pageof 63
Plos One|July 18, 2015
Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel AnalysisStephan Metz, Carl Ganter, Sylvie Lorenzen, et al.Frontiers in Psychology|September 9, 2020
COVID-19-Related Fear and Health-Related Safety Behavior in Oncological PatientsVenja Musche, Alexander Bäuerle, Jasmin Steinbach, et al.International Journal of Molecular Sciences|July 24, 2021
Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate CancerMagdalena Staniszewska, Pedro Fragoso Costa, Matthias Eiber, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2020
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysisRobert Seifert, Katharina Kessel, Katrin Schlack, et al.BMC Cancer|May 8, 2021
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocolJeremie Calais, Shaojun Zhu, Nader Hirmas, et al.Cancers|April 30, 2021
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCDavid Kersting, Robert Seifert, Lukas Kessler, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or NeuroblastomaInes Maric, Manuel Weber, Andre Prochnow, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed dosesJean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2018
Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancerJulian Kirchner, Lino M Sawicki, Felix Nensa, et al.European Radiology|April 26, 2017
Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CTLino M Sawicki, Cornelius Deuschl, Karsten Beiderwellen, et al.Pageof 63